A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

By Rishika Sadam HYDERABAD (Reuters) -Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for market share, data from research firm ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

We all know that regular exercise has many benefits, including reducing the risk of chronic diseases such as diabetes and ...

While most of us are familiar with type 1, type 2, and even gestational diabetes, there are actually six kinds of diabetes ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

A promising new insulin pill is just several months away from being trialled by people living with diabetes in ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...